Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 13.39 INR
Change Today +0.63 / 4.94%
Volume 181.0
PHRM On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

pharmasia ltd (PHRM) Snapshot

Open
12.26
Previous Close
12.76
Day High
13.39
Day Low
12.16
52 Week High
11/5/14 - 22.45
52 Week Low
09/9/14 - 8.30
Market Cap
91.4M
Average Volume 10 Days
184.1
EPS TTM
0.20
Shares Outstanding
6.8M
EX-Date
10/7/94
P/E TM
65.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMASIA LTD (PHRM)

Related News

No related news articles were found.

pharmasia ltd (PHRM) Related Businessweek News

No Related Businessweek News Found

pharmasia ltd (PHRM) Details

Phaarmasia Limited manufactures and sells pharmaceutical products and bulk drugs primarily in India. The company offers formulations, cosmetics and oral contraceptive pills. It also provides skin/face creams and tooth paste. The company was incorporated in 1981 and is based in Hyderabad, India.

Founded in 1981

pharmasia ltd (PHRM) Top Compensated Officers

Managing Director and Executive Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

pharmasia ltd (PHRM) Key Developments

Phaarmasia Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Phaarmasia Limited announced audited standalone earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company reported net sales/income from operations (excluding Branch transfer, excise duty) of INR 35.256 million compared to INR 29.661 million a year ago. Profit from operations before other income was INR 0.790 million compared to INR 0.430 million a year ago. Profit from ordinary activities before tax was INR 1.886 million compared to INR 0.253 million a year ago. Net profit for the period was INR 0.311 million compared to INR 0.047 million a year ago. Basic and diluted earnings per share after extraordinary items not annualized were INR 0.0455 against INR 0.0069 a year ago. For the year, the company reported net sales/income from operations (excluding Branch transfer, excise duty) of INR 123.030 million compared to INR 150.736 million a year ago. Profit from operations before other income was INR 2.671 million compared to INR 4.577 million a year ago. Profit from ordinary activities before tax was INR 3.637 million compared to INR 4.358 million a year ago. Net profit for the period was INR 1.396 million compared to INR 3.527 million a year ago. Basic and diluted earnings per share after extraordinary items not annualized were INR 0.2044 against INR 0.5167 a year ago.

Phaarmasia Limited, Board Meeting, May 29, 2015

Phaarmasia Limited, Board Meeting, May 29, 2015. Agenda: To consider audited standalone earnings results for the fourth quarter and full year ended March 31, 2015.

Phaarmasia Limited Appoints Rashmi V Sapte as Additional Director

Phaarmasia Ltd. announced that the Board of Directors of the company at its meeting held on February 14, 2015, has appointed Mrs. Rashmi V Sapte as additional director of the company with effect from February 14, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHRM:IN 13.39 INR +0.63

PHRM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHRM.
View Industry Companies
 

Industry Analysis

PHRM

Industry Average

Valuation PHRM Industry Range
Price/Earnings 64.5x
Price/Sales 0.7x
Price/Book 0.7x
Price/Cash Flow 10.0x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMASIA LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.